Molbio Diagnostics has debuted at Rs 980.00 on the BSE, up by 173.00 points or 21.44% from its issue price of Rs 807.
The scrip is currently trading at Rs. 1018.00, up by 211.00 points or 26.15% from its issue price.
It has touched a high and low of Rs. 1,044.75 and Rs. 925.80 respectively. So far 11.54 lakh shares were traded on the counter.
The offering, which was open for subscription August 10, 2026 and August 12, 2026 was subscribed 70.27 times. The issue price was fixed at Rs 807 per share i.e. at upper end of price band of Rs 768 - 807 apiece.
Molbio Diagnostics is an innovative point-of-care diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
